■ LECTURE OVERVIEW: Pompe Disease (Glycogen Storage Disease Type II) is a lysosomal storage disease that impairs the degradation of a small fraction of cellular glycogen, leading to multi-organ tissue destruction.
■ METABOLIC INFRASTRUCTURE:
1. Enzymatic Void: Autosomal recessive deficiency of Lysosomal Acid Alpha-1,4-Glucosidase (also called acid maltase).
2. Compartment Sequestration: Unlike other glycogen storage diseases, the defect is localized within lysosomes, which take up intracellular glycogen via autophagy but are unable to hydrolyze its alpha-1,4 and alpha-1,6 linkages.
3. Intralysosomal Glycogen Aggregation: Glycogen accumulates selectively within lysosomal vacuoles of major metabolically active tissues, primarily cardiac, skeletal, and smooth muscle fibers.
4. Myofibril Displacement: Cellular organelles are displaced, and myofibrillar architecture is completely disrupted by hypertrophying lysosomes, causing early muscle destruction.
■ RADIOGRAPHIC DIAGNOSTIC CRITERIA:
Imaging modalities (such as high-resolution CT, contrast-enhanced MRI, and point-of-care ultrasound) show characteristic density shifts, enhancement patterns, or structural deviations.
■ PROFESSOR'S CRITICAL SYNTHESIS:
Understanding the transition point from reversible cell injury to irreversible cellular death is the most fundamental concept in clinical medicine.
[HY-BOARD-1317]
🌟 Dynamic Clinical Key:
Infantile-onset Pompe disease presents with a classic triad: profound hypotonia (floppy infant), macroglossia, and massive hypertrophic cardiomyopathy resulting in early cardiorespiratory failure. 'Pompe trashes the Pump'—unlike other GSDs, patients have normal blood glucose levels as cytoplasmic glycogenolysis is fully intact. Always correlate imaging signs with clinical presentation to avoid unnecessary surgical explorations of benign incidentalomas. Connect microscopic cellular structure with patient presentation to develop a unified diagnostic vision.